Science
Praxis Precision Medicines Inc (NASDAQ:PRAX) Has Already Recovered 37.91%, But Another -113.56% Drop Cannot Be Ruled Out.
In last trading session, Praxis Precision Medicines Inc (NASDAQ:PRAX) saw 0.61 million shares changing hands with its beta currently measuring 2.63. Company’s recent per share
